Medtronic PLC Equity Alert: Contact Robbins LLP for Information Regarding the Lead Plaintiff Deadline in the Class Action Against Medtronic PLC (MDT)
28 sept. 2022 17h15 HE
|
Robbins LLP
SAN DIEGO, Sept. 28, 2022 (GLOBE NEWSWIRE) -- The Class: Shareholder rights law firm Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities...
Medtronic PLC Class Action Alert: If you Lost Money in Medtronic PLC (MDT) Contact Robbins LLP for Information About Your Rights
20 sept. 2022 13h01 HE
|
Robbins LLP
SAN DIEGO, Sept. 20, 2022 (GLOBE NEWSWIRE) -- The Class: Shareholder rights law firm Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities...
Medtronic plc Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm
15 sept. 2022 16h34 HE
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Sept. 15, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Medtronic plc (NYSE: MDT)...
GENETIC-AF Phase 2B Clinical Trial Atrial Fibrillation Burden (AFB) Results Presented at American Heart Association 2018 Scientific Sessions
12 nov. 2018 08h30 HE
|
ARCA biopharma, Inc.
AF detection by implanted Medtronic devicesSimilar trends for benefit in favor of Gencaro compared to active comparator for AF risk reduction observed by continuous monitoring with implanted devices...
ARCA biopharma and Medtronic Extend Gencaro Clinical Trial Collaboration Agreement
23 avr. 2018 08h30 HE
|
ARCA biopharma, Inc.
WESTMINSTER, Colo., April 23, 2018 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq:ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted...